AML Gene Panel Moves Targeted Sequencing Closer to Clinical Utility Memorial Sloan-Kettering’s Ross Levine is using a gene panel developed with RainDance to better understand leukemia and to stratify patient samples by predicted outcome. Ross Levine, an associate member of the Human O
Targeted Sequencing Offers a Leap Forward in Cancer Research UCSD researcher uses RainDance targeted sequencing of cancer hotspots to multiplex samples, boost sensitivity, specificity and utility, and dramatically lower per-sample costs. When translational genomics expert Olivier Hari
RainDance Technologies® is making complex genetics simple. The company’s ultra-sensitive genomic tools enable research of novel non-invasive liquid biopsy applications that should result in more accurate, reliable, cost-effective, and early detection of cancer and other inherited and infectious diseases. Major research institutions and laboratories around the world rely on the performance of RainDance systems. Based outside Boston, Massachusetts, the company supports customers using RainDrop® Digital PCR, as well as the ThunderStorm® and ThunderBolts™ Next-Generation Sequencing Enrichment Systems through its international sales and service operations, as well as a global network of distributors and commercial service providers. Both technology platforms have been recognized by The Scientist as Top 10 Innovations with the RainDrop System winning the award in 2014 and the ThunderStorm System winning the award in 2011.